Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

22 ta ish

Ish: Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

    Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

    MaqolaTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos
    ABI

  2. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

    Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

    Maqola201011 iqtibos
    ABI

  3. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

    Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

    Maqola20146 iqtibos
    ABI

  4. The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis

    Dennis Falzon, Ernesto Jaramillo, Holger J. Schünemann

    Maqola20115 iqtibos
    ABI

  5. Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

    K. J. M. Aung, Armand Van Deun, Erik De Clercq +4

    Maqola20145 iqtibos
    ABI

  6. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

    Christopher Kuaban, J Noeske, Hans L. Rieder +3

    Maqola20155 iqtibos
    ABI

  7. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

    Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch +13

    Maqola20144 iqtibos
    ABI

  8. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

    Catharina Boehme, Pamela Nabeta, Doris Hillemann +16

    Maqola20104 iqtibos
    ABI

  9. Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens

    Elizabeth M. Marlowe, Susan Novak-Weekley, Joven Cumpio +6

    Maqola20112 iqtibos
    ABI

  10. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

    Evan Orenstein, Sanjay Basu, N. Sarita Shah +5

    Sharh maqola20092 iqtibos
    ABI

  11. Research Protocol - Effectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, Uzbekistan

    Philipp du Cros, Khamraev Atadjan, Mirzagalib Tillashaikhov +19

    Maqola20142 iqtibos
    ABI

  12. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

    Rodney Dawson, Andreas H. Diacon, Daniel E. Everitt +16

    Maqola20152 iqtibos
    ABI

  13. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial

    Andrew Nunn, I. D. Rusen, Armand Van Deun +6

    Maqola20142 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI